• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A phase I/II study of salvage radiosurgery in the treatment of recurrent brain metastases.

作者信息

Davey P, O'Brien P F, Schwartz M L, Cooper P W

机构信息

Toronto-Bayview Regional Cancer Centre, Ontario, Canada.

出版信息

Br J Neurosurg. 1994;8(6):717-23. doi: 10.3109/02688699409101186.

DOI:10.3109/02688699409101186
PMID:7718169
Abstract

Radiosurgery has been advocated as a salvage treatment for relapsed patients with brain metastases. This report describes a phase I/II study of salvage radiosurgery for patients previously treated with whole brain irradiation. The study was opened in March 1989 and the last patient was treated in July 1992. All patients have been followed to recurrence at the radiosurgically treated site or to death. Twenty progressing metastases in 12 patients were treated using 14 radiosurgical procedures. The radiation dose was always 25 Gy with the 90% isodose volume encompassing all enhancing tumour. Nineteen metastases were evaluable at +4 weeks. There were no instances of progressive disease; there were three complete responses, six partial responses, and 10 metastases remained unchanged. Median survival from the date of radiosurgery was 6 months. Nine of 12 patients eventually failed at the radiosurgically treated site (two remain alive). Radiosurgery at the time of relapse provides temporary control of recurrent brain metastases with acceptable toxicity.

摘要

相似文献

1
A phase I/II study of salvage radiosurgery in the treatment of recurrent brain metastases.
Br J Neurosurg. 1994;8(6):717-23. doi: 10.3109/02688699409101186.
2
Gamma knife radiosurgery in the treatment of patients with single and multiple brain metastases from carcinoma of the breast.伽玛刀放射外科治疗乳腺癌单发和多发脑转移患者
Cancer J. 2000 Mar-Apr;6(2):88-92.
3
Radiation dose and incidence of new metastasis in the anterior temporal lobe structures of radiosurgically treated patients.放射治疗后患者前颞叶结构中新转移灶的辐射剂量和发生率。
J Neurosurg. 2010 Jan;112(1):122-9. doi: 10.3171/2009.4.JNS09249.
4
Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.对既往行放射外科治疗后局部复发的脑转移瘤行重复立体定向放射外科治疗作为挽救性治疗。
J Neurosurg. 2017 Jul;127(1):148-156. doi: 10.3171/2016.5.JNS153051. Epub 2016 Aug 5.
5
The role of cyberknife radiosurgery/radiotherapy for brain metastases of multiple or large-size tumors.射波刀立体定向放射手术/放射治疗在多灶性或大体积脑转移瘤治疗中的作用
Minim Invasive Neurosurg. 2006 Aug;49(4):203-9. doi: 10.1055/s-2006-947998.
6
Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.脑转移瘤立体定向放射治疗后的不良放射效应:发生率、时间进程及危险因素
J Neurosurg. 2015 Aug;123(2):373-86. doi: 10.3171/2014.10.JNS141610. Epub 2015 May 15.
7
Gamma knife radiosurgery for malignant melanoma brain metastases.伽玛刀放射外科治疗恶性黑色素瘤脑转移瘤。
Cancer J Sci Am. 1998 Mar-Apr;4(2):103-9.
8
Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.复发性脑转移瘤的多次场中放射外科治疗:在治疗密集的患者队列中的可行性、结果和生存。
PLoS One. 2018 Jun 6;13(6):e0198692. doi: 10.1371/journal.pone.0198692. eCollection 2018.
9
Gamma knife radiosurgery of a series of only minimally selected metastatic brain tumours.对一系列仅经过最低限度筛选的脑转移瘤进行伽玛刀放射外科治疗。
Acta Neurochir Suppl. 1994;62:77-82. doi: 10.1007/978-3-7091-9371-6_16.
10
Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications.伽玛刀放射外科治疗转移性黑色素瘤:生存、结局及并发症分析
Neurosurgery. 1999 Jan;44(1):59-64; discussion 64-6. doi: 10.1097/00006123-199901000-00031.

引用本文的文献

1
Efficacy and Safety of a Second Course of Stereotactic Radiation Therapy for Locally Recurrent Brain Metastases: A Systematic Review.立体定向放射治疗局部复发性脑转移瘤第二疗程的疗效与安全性:一项系统评价
Cancers (Basel). 2021 Sep 30;13(19):4929. doi: 10.3390/cancers13194929.
2
Clinical Experience of Bevacizumab for Radiation Necrosis in Patients with Brain Metastasis.贝伐单抗治疗脑转移患者放射性坏死的临床经验
Brain Tumor Res Treat. 2020 Oct;8(2):93-102. doi: 10.14791/btrt.2020.8.e11. Epub 2020 Jul 9.
3
Tumor control and incidence of radiation necrosis after reirradiation with stereotactic radiosurgery for brain metastases.
立体定向放射外科再照射治疗脑转移瘤后的肿瘤控制及放射性坏死发生率
J Radiosurg SBRT. 2014;3(1):21-28.
4
The efficacy and limitations of stereotactic radiosurgery as a salvage treatment after failed whole brain radiotherapy for brain metastases.立体定向放射外科作为全脑放疗治疗脑转移失败后的挽救性治疗的疗效和局限性。
J Neurooncol. 2013 Jul;113(3):459-65. doi: 10.1007/s11060-013-1138-y. Epub 2013 May 10.
5
Hippocampal avoidance with volumetric modulated arc therapy in melanoma brain metastases - the first Australian experience.容积旋转调强弧形治疗在黑素瘤脑转移瘤中的海马回避作用——澳大利亚的首次经验。
Radiat Oncol. 2013 Mar 18;8:62. doi: 10.1186/1748-717X-8-62.
6
Chemosensitized radiosurgery for recurrent brain metastases.化疗增敏放疗治疗复发性脑转移瘤。
J Neurooncol. 2012 Nov;110(2):265-70. doi: 10.1007/s11060-012-0965-6. Epub 2012 Aug 22.
7
Current standards in the management of cerebral metastases.脑转移瘤管理的当前标准。
Int J Surg Oncol. 2012;2012:493426. doi: 10.1155/2012/493426. Epub 2011 Nov 10.
8
Gamma knife stereotactic radiosurgery for the management of incidentally-identified brain metastasis from non-small cell lung cancer.伽玛刀立体定向放射外科治疗非小细胞肺癌偶然发现的脑转移瘤。
J Neurooncol. 2011 Sep;104(3):817-24. doi: 10.1007/s11060-011-0553-1. Epub 2011 Mar 23.
9
The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline.复发性/进展性脑转移瘤治疗中再治疗的作用:系统评价和循证临床实践指南。
J Neurooncol. 2010 Jan;96(1):85-96. doi: 10.1007/s11060-009-0055-6. Epub 2009 Dec 3.
10
A phase II trial of temozolomide for patients with recurrent or progressive brain metastases.替莫唑胺用于复发性或进行性脑转移瘤患者的II期试验。
J Neurooncol. 2001 Jul;53(3):259-65. doi: 10.1023/a:1012226718323.